Clinical study for a new detection index for liver injury

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023406

Enrollment

Unknown

Registered

2019-05-26

Start date

2019-05-27

Completion date

Unknown

Last updated

2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver injury

Interventions

Gold Standard:liver fuction?ALT?AST

Index test:Sulfhydryl&#32

Total&#32

Oxide&#32

Capability&#32

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Health check-up, hypertension, type 2 diabetes mellitus, liver-related tumors and non-liver-related tumors.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Liver fuction;ALT;AST;Sulfhydryl Total Oxide Capability;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactZhenhua Zhang

The Second Hospital of Anhui Medicine University

zzh1974cn@126.com+86 13215510411

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026